| 24 Novembre 2020
HIV Pioneer and world-renowned scientist to advise NeuroCytonix as it develops technology to improve the lives of patients suffering from neurological disorders
Rockville, Maryland, November 9, 2020 — NeuroCytonix Inc., a company developing a first-in-class platform to treat incurable neurological conditions, is pleased to announce that Robert Gallo, M.D., has joined their Scientific Board. Dr. Gallo is best known for his discovery of HIV, the cause of AIDS, and is an internationally recognized expert on biomedical research.
“It is a great honor and vote of confidence to welcome Dr. Gallo as a member of our Scientific Board,” said J. Robert Trujillo, M.D., Sc.D., founder, chairman and CEO of NeuroCytonix. “My mission is to ‘Cure the Incurable’ and Dr. Gallo’s deep scientific expertise and leadership will be invaluable as we work to bring our disruptive technology to those in need.”
NeuroCytonix has developed cutting-edge medical biotechnology focused on tissue engineering and regeneration. This technology and its related protocols are dramatically improving patients suffering from neurodegenerative diseases and disorders such as cerebral palsy, stroke, traumatic brain injuries (TBI), Alzheimer's, Parkinson’s, autism and schizophrenia.
Robert Gallo, M.D.
Dr. Robert Gallo is best known for his discovery of HIV, the cause of AIDS. Dr. Gallo and his team would go on to make advancements in the treatment of AIDS and other viral chronic diseases. Today, Dr. Gallo continues his scientific research as the director of the Institute of Human Virology at the University of Maryland School of Medicine. Early in his career, Dr. Gallo became a researcher at the National Cancer Institute, where he worked for 30 years as head of the Laboratory of Tumor Cell Biology. Dr. Gallo became the most referenced scientist in the world in the 1980s and 1990s, as well as twice winning America’s most prestigious scientific award, the Albert Lasker Award in Medicine. Born in Waterbury, Connecticut, he earned a B.S. degree in Biology from Providence College and an M.D. from Jefferson Medical College.
J. Robert (J.R.) Trujillo, M.D., Sc.D.
Founder, Chairman and CEO, NeuroCytonix Inc.
Dr. J.R. Trujillo is a physician, scientist, inventor and entrepreneur who has spent his life studying neurosciences, neurovirology and molecular virology. Dr. Trujillo’s dedicated and pioneering work has been recognized through numerous awards, professional titles and honorary doctoral degrees. The Mexican government named him one of the 100 Most Influential Professional Mexicans in the U.S. and awarded him the Ohtli Award, the highest honor awarded to recognize individuals of Mexican heritage. Dr. Trujillo has an M.D. from the University Autonomous of Mexico State and an Sc.D. in Neuroscience and Molecular Virology from Harvard University, where he held several faculty positions and founded the Pan-American Society of NeuroVirology.
About NeuroCytonix Inc.
NeuroCytonix Inc., was founded by Dr. J.R. Trujillo to find cures for incurable neurological disease. The company’s goal is to help people around the world with treatments for a range of diseases of the brain and nervous system.ÂÂ ÂÂ NeuroCytonix is currently developing treatments for incurable neurological conditions including cerebral palsy, stroke and traumatic brain injuries (TBI). NeuroCytonix technology and its related protocols are a new approach to the treatment of neurodegenerative diseases. Currently, NeuroCytonix is implementing its first U.S. Food and Drug Administration (FDA) controlled clinical trial for cerebral palsy.
